| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
| Qu'est-ce que c'est le code ATC? | Index ATC |
|
| | | IPro | | | Magnevist 2 mmol/L | 20 ml | 47.63 | 71.10 | 10% | | Solution injectable en seringue prête à l'emploi: Dimeglumini Gadopentetas 1.876 mg/ml | Bayer (Schweiz) AG | B / LS | FB | | G |  |
| | | IPro | | | Magnevist | flacon(s) à 10 ml | 70.82 | 97.70 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | seringue(s) à 10 ml | 70.82 | 97.70 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | flacon(s) à 15 ml | 96.28 | 126.95 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | seringue(s) à 15 ml | 96.28 | 126.95 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | flacon(s) à 20 ml | 122.15 | 156.65 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | seringue(s) à 20 ml | 122.15 | 156.65 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | flacon(s) à 30 ml | 177.09 | 219.70 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | 5 1 seringue(s) à 10 ml | 351.51 | 430.30 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | 5 1 seringue(s) à 15 ml | 479.38 | 580.90 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | 5 1 seringue(s) à 20 ml | 604.81 | 728.60 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Magnevist | flacon(s) à 100 ml | 655.36 | 768.75 | N.O. | | Solution injectable: Dimeglumini Gadopentetas 469 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
|
| | | IPro | | | Dotarem | 10 ml | 51.38 | 75.40 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Dotarem | 10 ml | 51.38 | 75.40 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Dotarem | 15 ml | 69.82 | 96.55 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Dotarem | 15 ml | 69.82 | 96.55 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Dotarem | 20 ml | 88.23 | 117.70 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Dotarem | 20 ml | 88.23 | 117.70 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Dotarem | 60 ml | 264.69 | 320.25 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS / SO | FB | | G | |
| | | IPro | | | Clariscan | 10 ml | 37.07 | 58.95 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 10 ml | 37.07 | 58.95 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 15 ml | 50.37 | 74.20 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 15 ml | 50.37 | 74.20 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 20 ml | 63.65 | 89.45 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 20 ml | 63.65 | 89.45 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 50 ml | 148.28 | 178.65 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Clariscan | 100 ml | 296.56 | 356.85 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Dotagraf | 10 ml | 37.07 | 58.95 | 10% | | Solution injectable: Acidum Gadotericum 279.32 mg | Berlis AG | B / LS / SG | FB | | G | |
| | | IPro | | | Dotagraf | 15 ml | 50.37 | 74.20 | 10% | | Solution injectable: Acidum Gadotericum 279.32 mg | Berlis AG | B / LS / SG | FB | | G | |
| | | IPro | | | Dotagraf | 20 ml | 63.65 | 89.45 | 10% | | Solution injectable: Acidum Gadotericum 279.32 mg | Berlis AG | B / LS / SG | FB | | G | |
| | | IPro | | | Dotagraf | 60 ml | 177.94 | 220.70 | 10% | | Solution injectable: Acidum Gadotericum 279.32 mg | Berlis AG | B / LS / SG | FB | | G | |
| | | IPro | | | Dotagraf | 100 ml | 296.56 | 356.85 | 10% | | Solution injectable: Acidum Gadotericum 279.32 mg | Berlis AG | B / LS / SG | FB | | G | |
| | | IPro | | | Artirem | seringue(s) à 20 ml | 50.12 | 73.95 | 10% | | Solution injectable: Acidum Gadotericum 1.397 mg/ml | Guerbet AG | B / LS | FB | | G | |
| | | IPro | | | Artirem | Flacon perforable à 20 ml | 43.02 | 65.80 | 10% | | Solution injectable: Acidum Gadotericum 1.397 mg/ml | Guerbet AG | B / LS | FB | | G | |
| | | IPro | | | Dotarem | 10 ml | 51.38 | 75.40 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS | FB | | G | |
| | | IPro | | | Dotarem | 15 ml | 69.82 | 96.55 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS | FB | | G | |
| | | IPro | | | Dotarem | 20 ml | 88.23 | 117.70 | 10% | | Solution injectable: Acidum Gadotericum 279.3 mg/ml | Guerbet AG | B / LS | FB | | G | |
| | | IPro | | | Clariscan | 50 ml | DDP | DDP | N.O. | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Clariscan | 60 ml | DDP | DDP | N.O. | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Clariscan | 100 ml | DDP | DDP | N.O. | | Solution injectable: Acidum Gadotericum 279.3 mg | GE Healthcare AG | B | FB | | G | |
|
| | | IPro | | | Omniscan | 10 ml | 51.57 | 75.60 | 10% | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B / LS | FB | | G | |
| | | IPro | | | Omniscan | 10 ml | 51.57 | 75.60 | 10% | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B / LS | FB | | G | |
| | | IPro | | | Omniscan | 15 ml | 78.61 | 106.65 | 10% | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B / LS | FB | | G | |
| | | IPro | | | Omniscan | 15 ml | 77.79 | 105.70 | 10% | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B / LS | FB | | G | |
| | | IPro | | | Omniscan | 20 ml | 101.72 | 133.15 | 10% | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B / LS | FB | | G | |
| | | IPro | | | Omniscan | 20 ml | 97.67 | 128.55 | 10% | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B / LS | FB | | G | |
| | | IPro | | | Omniscan | 50 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 100 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 15 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 15 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 20 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 20 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 50 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
| | | IPro | | | Omniscan | 10 x 100 ml | DDP | DDP | N.O. | | Solution injectable: Gadodiamidum 287 mg | GE Healthcare AG | B | FB | | G | |
|
| | | IPro | | | ProHance 0.5 mmol/ml | flacon(s) à 10 ml | 50.70 | 74.60 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | flacon(s) à 15 ml | 77.06 | 104.85 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | flacon(s) à 20 ml | 99.74 | 130.90 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | flacon(s) à 50 ml | 253.50 | 307.40 | 10% | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 10 ml | 54.60 | 79.10 | 10% | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 17 ml | 87.17 | 116.45 | 10% | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 10 1 flacon(s) à 10 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 10 1 flacon(s) à 15 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 10 1 flacon(s) à 20 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 x 17 ml | DDP | DDP | N.O. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | flacon(s) à 5 ml | 27.63 | 48.10 | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 1 flacon(s) à 5 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 10 1 flacon(s) à 5 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 1 flacon(s) à 10 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 1 flacon(s) à 15 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 20 1 flacon(s) à 5 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 1 flacon(s) à 20 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 20 1 flacon(s) à 10 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 20 1 flacon(s) à 15 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 20 1 flacon(s) à 20 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 10 1 flacon(s) à 50 ml | DDP | DDP | N.O. | | soluzione iniettabile (flacone): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 15 ml | DDP | DDP | N.O. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 x 10 ml | DDP | DDP | N.O. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
| | | IPro | | | ProHance 0.5 mmol/ml | 5 x 15 ml | DDP | DDP | N.O. | | soluzione iniettabile (siringa di iniezione preriempita): Gadoteridolum 279.3 mg | Bracco Suisse SA | B | FB | | G | |
|
| | | IPro | | | MultiHance | Vial(s) à 10 ml | 51.97 | 76.05 | 10% | | Solution injectable: 2 Principes actifs | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | MultiHance | 10 ml | 51.97 | 76.05 | 10% | | Solution injectable: 2 Principes actifs | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | MultiHance | Vial(s) à 15 ml | 70.68 | 97.55 | 10% | | Solution injectable: 2 Principes actifs | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | MultiHance | 15 ml | 70.68 | 97.55 | 10% | | Solution injectable: 2 Principes actifs | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | MultiHance | Vial(s) à 20 ml | 89.38 | 119.00 | 10% | | Solution injectable: 2 Principes actifs | Bracco Suisse SA | B / LS | FB | | G | |
| | | IPro | | | MultiHance | 20 ml | 89.38 | 119.00 | 10% | | Solution injectable: 2 Principes actifs | Bracco Suisse SA | B / LS | FB | | G | |
|
| | | IPro | | | Gadovist 1,0 | 2 ml | 15.06 | 33.70 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 5 ml | 51.86 | 75.95 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 7.5 ml | 77.79 | 105.70 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 10 ml | 88.17 | 117.60 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 15 ml | 140.99 | 178.25 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | pièce(s) à 15 ml | 140.99 | 178.25 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | flacon(s) à 30 ml | 225.99 | 275.85 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | flacon(s) à 65 ml | 466.62 | 552.10 | 10% | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 5 ml | DDP | DDP | N.O. | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 7.5 ml | DDP | DDP | N.O. | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 10 ml | DDP | DDP | N.O. | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
| | | IPro | | | Gadovist 1,0 | seringue(s) à 15 ml | DDP | DDP | N.O. | | Solution injectable: Gadobutrolum 604.72 mg | Bayer (Schweiz) AG | B | FB | | G | |
|
| | IBP | IPro | | | Primovist 0.25 mmol/ml | seringue(s) | 180.26 | 223.35 | 10% | | Solution injectable: Dinatrii Gadoxetas 181.43 mg/ml | Bayer (Schweiz) AG | B / LS | FB | | G | |
| | IBP | IPro | | | Primovist 0.25 mmol/ml | | DDP | DDP | N.O. | | Solution injectable: Dinatrii Gadoxetas 181.43 mg/ml | Bayer (Schweiz) AG | B | FB | | G | |
